Three ways we work with you
We don't describe services — we deliver outcomes. Here's what you get.
We actively scan the European market for products that match your portfolio criteria — generics, OTC, or specialty. You get a structured opportunity report every month with commercial, regulatory and supply assessment included.
- Shortlisted opportunities with scoring
- Initial partner outreach handled
- Commercial and patent pre-screening
From MA strategy to first sale — we manage the full Nordic market entry for your product. Regulatory pathway, distributor selection, pricing, channel setup and launch plan. One point of contact. Fixed scope.
- Full Nordic regulatory strategy
- Distributor and partner identification
- Launch plan with KPIs and timeline
You've found a potential asset, partner or deal. We run a structured commercial and regulatory due diligence — fast. You get a clear go/no-go recommendation with the data to back it up.
- Commercial market sizing
- Regulatory risk assessment
- Supply chain and patent review
Dan Kyster Hartwig
Founder · DH Nordic Pharma Consultancy
15+ years as Head of Business Development at two of Denmark's largest generics companies — Orifarm Generics and 2care4. Closed licensing, supply and asset deals across Europe and Asia. Member of the board at Orifarm Group.
Today I work as a fractional BD partner for pharma companies that need senior execution without a full-time hire.
Ready to talk?
A 30-minute call costs nothing. Let's find out if we're a fit.